potential indications for glp-1 receptor agonists keep expanding are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Frontiers | Unlocking the potential

The first medication that targets neurotransmitter systems other than dopamine has been approved for use

This narrative review highlights four human clinical trials by showcasing the benefits of Setria Glutathione when combined with citrulline

Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

However, unlike endogenous enkephalins that target opioid receptors, GHRPs activate the receptors for the hunger hormone ghrelin

The significance of HO1 in ferroptosis has been shown in various pathological states such as liver injury, testicular injury, and colitis in different animal models [26,27,28]

Furthermore, reporting adhered to the ARRIVE guidelines for reporting animal experiments